Peptide Diagnostic
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
37
NCT01476332
Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2011
Completion: Mar 31, 2012
Loading map...